Is Concentrix Corp. overvalued or undervalued?

As of 31 October 2025, the valuation grade for Concentrix Corp. has moved from fair to attractive, indicating a more favorable assessment of its value. The company appears undervalued, supported by a P/E ratio of 11, a price-to-book value of 0.90, and an EV to EBITDA ratio of 5.71. In comparison, Genpact Ltd. has a higher P/E ratio of 14.38, while ADT, Inc. shows a more favorable EV to EBITDA of 5.12, highlighting Concentrix's relative attractiveness in the market.
Despite the positive valuation indicators, Concentrix has underperformed against the S&P 500, with a year-to-date return of -6.84% compared to the index's 16.30%. This underperformance, particularly over the past three years where the stock has declined by 67.02% against a 76.66% gain for the S&P 500, suggests that while the company is currently undervalued, market sentiment may still be a concern.